These mid-cap stocks were the best performers in the last week. Are they in your portfolio?

Hims & Hers Health (HIMS) stock could soon stage a rebound, creating an intriguing opportunity for options bulls ...

Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...

BofA Securities has recently reduced Hims & Hers Health Inc (HIMS) stock to Underperform rating, as announced on November 14, 2024, according to Finviz. Earlier, on August 22, 2024, Needham had ...

The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...

Citi notes that the FDA said in a status report filed in a Texas court that it needs more time to determine if Eli Lilly’s (LLY) tirzepatide ...

Schrödinger is an unusual animal in the AI in drug discovery landscape. In a new interview with CEO Ramy Farid, STAT’s ...

While the biggest driver of growth for Amazon (NASDAQ: AMZN) has been coming from its cloud computing division, Amazon Web ...

Hims & Hers' financials are robust, with strong and accelerating revenue growth, growing free cash flow, manageable SBC, and ...

On Friday, Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $19.32 which represents a decrease of $-1.53 or -7.34% from the prior close of $20.85. The stock opened at $21.34 and ...

Kennedy Jr. nor Donald Trump can save Americans from the consequences of their own eating behavior. For several months, a ...

Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official Deb Autor to its board. The stock was up 8.8% at $21.02 in Monday trading. Shares have doubled ...